Chronic News and Research

RSS

Study: New Medicine Service could save NHS England £517.6m

A scheme launched by the Department of Health in 2011 to help patients stick to their drug regimens has been so successful, that in its first five years, it will save NHS England £517.6m in the long-term, a team of health economists has found.

From The University of Manchester 7 Aug 2017

Congress revamps housing program to benefit areas where HIV is spreading

In a bipartisan push, Congress has restructured a federal program that provides housing assistance for people living with HIV to funnel more money into areas struggling to control the outbreak.

7 Aug 2017

Social isolation and loneliness is a greater threat to public health than obesity, study states

A research presented at the 125th Annual Convention of the American Psychological Association on 5th August 2017 suggests that a higher public health hazard might be represented by loneliness and social isolation than obesity.

7 Aug 2017

Opioid prescription use found to be more common among cancer survivors

A new study found that opioid prescription use is more common in cancer survivors than in individuals without a history of cancer.

7 Aug 2017

HIV prevention and treatment being overlooked in older populations

When it comes to HIV prevention and treatment, there is a growing population that is being overlooked -- older adults -- and implicit ageism is partially responsible for this neglect, according to a presentation at the 125th Annual Convention of the American Psychological Association.

4 Aug 2017

Protein that protects fetus during pregnancy could help treat atopic dermatitis

A protein which protects the fetus during pregnancy, HLA-G1, shows high potential for treating atopic dermatitis and other related diseases.

4 Aug 2017

Advanced statistical modeling and analytic tools can make health care, medical data more meaningful

Recognizing that administrative health care databases can be a valuable, yet challenging, tool in the nation's ongoing pursuit of personalized medicine, statisticians Liangyuan Hu and Madhu Mazumdar of the Icahn School of Medicine at Mount Sinai have developed advanced statistical modeling and analytic tools that can make health care and medical data more meaningful.

4 Aug 2017

Smell loss linked to worse nutritional status in patients with chronic kidney disease

A new study indicates that many patients with chronic kidney disease (CKD) have some degree of smell loss, and that impairments in patients' ability to smell are linked with worse nutritional status.

4 Aug 2017

New study shows how gut microbes can prevent severe flu infections in mice

Microbes that live in the gut don't just digest food. They also have far-reaching effects on the immune system.

3 Aug 2017

Yoga appears to lessen symptoms of depression

People who suffer from depression may want to look to yoga as a complement to traditional therapies as the practice appears to lessen symptoms of the disorder, according to studies presented at the 125th Annual Convention of the American Psychological Association.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Under Trump, hospitals face same penalties embraced by Obama

Amid all the turbulence over the future of the Affordable Care Act, one facet continues unchanged: President Donald Trump's administration is penalizing more than half the nation's hospitals for having too many patients return within a month.

3 Aug 2017

Study findings could lead to more effective and faster acting antidepressants

For people suffering from depression, a day without treatment can seem like a lifetime. A new study explains why the most commonly prescribed antidepressants can take as long as six weeks to have an effect. The findings could one day lead to more effective and faster acting drugs.

3 Aug 2017

Researchers develop potential stem cell treatment for several lung conditions

A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis -- often-fatal conditions that affect tens of millions of Americans.

3 Aug 2017

Botulinum neurotoxin type X holds potential to open up new field of toxin therapeutics

Botulinum toxins are currently used on more than 80 medical conditions including Muscle spasms, Overactive bladder, Chronic migraine, Cervical dystonia, Sweating and Cerebral Palsy (CP).

3 Aug 2017

When wounds won’t heal, therapies spread — to the tune of $5 billion

Carol Emanuele beat cancer. But for the past two years, she has been fighting her toughest battle yet. She has an open wound on the bottom of her foot that leaves her unable to walk and prone to deadly infection.

3 Aug 2017

Tiny molecule in the immune system could help develop cure for common cold

A tiny molecule found in the immune systems of humans and animals could be used to develop a cure for the common cold, new research suggests.

3 Aug 2017

Mango intake exerts beneficial effects in progression and severity of IBD

Initial results of a study by researchers in the department of nutrition and food science at Texas A&M University in College Station show mango consumption has a positive impact on people with inflammatory bowel disease.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017